The Science Advisory Board

President Biden launches $50M initiative to improve cancer outcomes in low-income areas

The Biden-Harris administration on Monday awarded $50 million to launch the Persistent Poverty Initiativ...

3D cellular models identify potential drug target for preventing Alzheimer’s

A 3D cellular model has shown that mutations affec...

Gene mutations linked to drug-resistant liver cancer

Certain gene mutations could serve as markers to hel...

Potential treatment for rare autoimmune disorder adapted from CAR-T therapy in study

Evidence from a small-scale clinical trial suggest...

FDA approves first gene therapy for treatment of certain patients with Duchenne muscular dystrophy

The U.S. Food and Drug Administration (FDA) on Thursda...

Cancer & Disease Research

Lunaphore launches Comet antibody instrument in U.K.
May 9, 2022 -- Lunaphore installed its Comet Primary Antibodies instrument at Propath U.K., the first contract research organization in Europe to offer the service. Read More

Cybin, Kernel tout study of ketamine's effects on brain
May 9, 2022 -- Kernel's neuroimaging technology successfully measured the neuroeffect of ketamine over 11 days, according to the results of a pilot study from the biopharmaceutical firm Cybin. Read More